Skip to main content
. 2023 Oct 20;16(10):1492. doi: 10.3390/ph16101492

Figure 4.

Figure 4

Observation of the skin structure with the treatment of PBS, CLD, CLD-hFGF2, and hFGF2 freeze-dried powder. (A) Analysis for the components of the CLD-hFGF2 freeze-dried powder. (B) Analysis for the DSC thermograms of skin treated with PBS, hFGF2, CLD, and CLD-hFGF2 freeze-dried powder. (C,D) Analysis for the FITR of skin treated with PBS, hFGF2, CLD, and CLD-hFGF2 freeze-dried powder.